Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Syngene to expand its R&D center serving BMS

by Rick Mullin
May 7, 2021 | A version of this story appeared in Volume 99, Issue 17

 

Syngene International will add a 4,600 m2 facility in Bangalore, India, to an R&D center dedicated to Bristol Myers Squibb. The pharmaceutical services firm will also add 200 researchers—a 40% increase—to its staff as part of an extension of its contract with the US drugmaker through 2030. Syngene has worked with BMS since 1998 and established the dedicated research facility in 2009. The center is the largest BMS R&D site run by a partner, Syngene says.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.